Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutinin-induced proliferation and interleukin-2 production of human lymphocytes

Digestive Diseases and Sciences

Volumn 41, Issue 7, 1996, Pages 1468-1474

  Haga, Yoshio ^b   Tempero, Margaret A ^a   Kay, David ^b   Zetterman, Rowen K ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b NONE

Author keywords

bilirubin; immune function; interleukin 2; lymphocyte proliferation

Indexed keywords

BILIRUBIN; INTERLEUKIN 2; PHYTOHEMAGGLUTININ;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BILIRUBIN; DNA; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TRANSFERRIN;

EID: 0030036986     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088574     Document Type: Article

References (42)

1. Pearlman MA, Gartner LM, Lee KS, Eidelman AI, Morecki R, Horoupian DS: The association of kernicterus with bacterial infection in the newborn. Pediatrics 65:26-29, 1980
2. Armstrong CP, Dixon JM, Taylor TV, Davies GC: Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 71:234-238, 1984
3. Holman JM, Rikkers LF, Moody FG: Sepsis in the management of complicated biliary disorders. Am J Surg 138:809-813, 1979
4. Pitt HA, Cameron JL, Postier RG, Gadacz TR: Factors affecting mortality in biliary tract surgery. Am J Surg 141:66-72, 1981
5. Ansaldi N, Fiandino G. Ciriotti G: Changes of the immunoglobulin level in hyperbilirubinemic premature infants. Minerva Pediatr 20:1982-1984, 1968
6. Nejedla Z: The development of immunological factors in infants with hyperbilirubinemia. Pediatrics 45:102-104, 1970
7. Diaz del Castillo E: Neonatal hyperbilirubinemia. Its relation to the immunological response capacity of the newborn infant. Gac Med Mex 105:185-207, 1973
8. Newble DI, Holmes KT, Wangel AG, Forbes IJ: Immune reactions in acute viral hepatitis. Clin Exp Immunol 20:17-28, 1974
9. Newberry WM, Shorey JW, Sanford JP, Combes B: Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cell Immunol 6:87-97, 1973
10. Haga Y, Sakamoto K, Egami H, Yokoyama Y, Arai M, Mori K, Akagi M: Changes in production of interleukin 1 and interleukin 2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer. Surgery 106:842-848, 1989
11. Roughneen PT, Gouma DJ, Kulkarni AD, Fanslow WF, Rowlands BJ: Impaired specific cell mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage. J Surg Res 41:113-125, 1986
12. Megison SM, Dunn CW, Horton JW, Chao H: Immunologic recovery after biliary drainage in obstructive jaundice. Curr Surg 5:383-385, 1989
13. Thompson RLE, Diamond MHT, Rowlands BJ: Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg 77:1229-1232, 1990
14. Megison SM, Dunn CW, Horton JW, Chao H: Effects of relief of biliary obstruction on mononuclear phagocyte system function and cell mediated immunity. Br J Surg 78:568-571, 1991
15. Nie CH, Grogan JB, Crick MP, Connor CE: Impaired response to alloantigens in murine biliary obstruction. J Surg Res 54:145-149, 1993
16. Desmet VJ: Morphologic and histochemical aspects of cholestasis. In Progress in Liver Diseases, Vol. IV. H Popper, F Schaffner (eds). New York, Grune & Stratton, 1972, pp 97-132
17. Rola-Pleszczynski M, Hensen SA, Vincent MM, Bellanti JA: Inhibitory effect of bilirubin on cellular immune responses in man. J Pediatr 86:690-696, 1975
18. Thong YH, Ness D, Ferrante A: Effect of bilirubin on the fungicidal capacity of human neutrophils. Sabouraudia 17:125-129, 1979
19. Sima P, Mala J, Miler I, Hodr R, Truxova E: The suppressive effect of continuous infusion of bilirubin on the immune response in mice. Folia Microbiol 25:483-490, 1980
20. Miler I, Vondracek J, Hromadkova L: Bilirubin inhibits the chemotactic activity of human polymorphonuclear leukocytes in vitro. Folia Microbiol 26:413-416, 1981
21. Svejcar J, Miler I, Pekarek J: Effect of bilirubin on an in vitro correlate of cell mediated immunity - the migration inhibition test. J Clin Lab Immunol 13:145-149, 1984
22. Miler I, Vetvicka V, Sima P, Hodr R, Truxova E: The effect of bilirubin on the phagocytic activity of mouse peripheral granulocytes and monocytes in vivo. Folia Microbiol 30:267-271, 1985
23. Vetvicka V, Miler I, Sima P, Taborsky L, Fornusek L: The effect of bilirubin on the Fc receptor expression and phagocytic activity of peritoneal macrophages. Folia Microbiol 30:373-380, 1985
24. Nakamura H, Uetani Y, Komura M, Takada S, Sano K, Matsuo T: Inhibitory action of bilirubin on superoxide production by polymorphonuclear leukocytes. Biol Neonate 52:273-278, 1987
25. Feduccia TD, Scott-Conner CEH, Grogan JB: Profound suppression of lymphocyte function in early biliary obstruction. Am J Med Sci 296:39-44, 1988
26. Gianni L, Di Padova F, Zuin M: Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: An in vitro study. Gastroenterology 78:231-235, 1980
27. Greve JW, Gouma DW, Soeters PB: Suppression of cellular immunity in obstructive jaundice is caused by endotoxins: A study with germ-free rats. Gastroenterology 98:478-485, 1990
28. Neckers LM, Cossman J: Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and regulated by interleukin-2. Proc Natl Acad Sci USA 80:3494-3498, 1983
29. Smith KA, Cantrell DA: Interleukin-2 regulates its own receptors. Proc Natl Acad Sci USA 82:864-868, 1985
30. Gutgsell NS, Malek TR: Formation of high affinity IL-2 receptors is dependent on a nonligand binding region of the α subunit. J Immunol 153:3899-3907, 1994
31. Tanaka T, Saiki O, Doi S, Negoro S, Kishimoto S: Interleukin 2 functions through novel inlerleukin 2 binding molecules in T cells. J Immunol 140:470-473, 1988
32. Kumagai N, Benedict SH, Mills GB, Gelfand EW: Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. J Immunol 140:37-43, 1988
33. Haga Y, Kay HD, Tempero MA, Zetterman RK: Flow cytometric measurement of intracellular bilirubin in human peripheral blood mononuclear cells exposed to unconjugated bilirubin. Clin Biochem 25:277-283, 1992
34. Haga Y, Tempero MA, Kay HD, Zetterman RK: Characterization of bilirubin transport system by human peripheral blood mononuclear cells. J Leukocyte Biol 51:2-6, 1992
35. Kay HD, Petrie HT, Burge JJ, Klassen LW: Rapid recovery of non-hemolyzed serum and untraumatized cells by using a new method of blood defibrination in vitro. J Immunol Methods 92:251-260, 1986
36. Kumagai K, Itoh K, Hinuma S: Pretreatment of plastic petri dishes with fetal calf serum. A simple method for macrophage isolation. J Immunol Methods 29:17-25, 1979
37. Lee KC, Shiozawa C, Shaw A, Diener F: Requirement of accessory cells in the antibody response to T cell-independent antigens in vitro. Eur J Immunol 6:63-68, 1976
38. Gillis S, Ferm MM, Ou W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027-2032, 1978
39. Le Bouteiller PP, Mishal Z, Lemonnier FA, Kourilsky FM: Quantification by flow cytofluorimetry of HLA class I molecules at the surface of murine cells transformed by cloned HLA genes. J Immunol Methods 61:301-315, 1983
40. Brodersen R: Aqueous solubility, albumin binding, and tissue distribution of bilirubin. In Bile Pigments and Jaundice. JE Ostrow (ed). New York, Marcel Dekker, 1986, pp 157-181
41. Suzuki N, Yamaguchi T, Nakajima H: Role of high-density lipoprotein in transport of circulating bilirubin in rats. J Biol Chem 263:5037-5043, 1988
42. Forni G, Giovarelli M, Santoni A, Modesti A, Forni M: Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol 138:4033-4041, 1987